Ocular Surface Syndrome Post-lasik, Outcomes of Treatment With Platelet Rich Plasma

Phase 2 Completed 80 enrolled Vissum, Instituto Oftalmológico de Alicante

NaSingle-groupOpen-labelTreatment

Summary

To evaluate the efficacy of autologous platelet-rich plasma eye drops (E-PRP) for the treatment of chronic ocular surface syndrome (OSS) following laser in situ keratomileusis (LASIK).

Timeline

Start: 2008-07-01
Primary completion: 2013-01-17
Completion: 2013-01-17

Publications

Alio JL, Rodriguez AE, Abdelghany AA, Oliveira RF. Autologous Platelet-Rich Plasma Eye Drops for the Treatment of Post-LASIK Chronic Ocular Surface Syndrome. J Ophthalmol. 2017;2017:2457620. doi: 10.1155/2017/2457620. Epub 2017 Dec 12.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Platelet Rich Plasma	Other / unclassified	1 unknown	Topical

Ocular Surface Syndrome Post-lasik, Outcomes of Treatment With Platelet Rich Plasma

Summary

Timeline

Publications

Drugs

Indications